| [1] |
崔炯，万建新．高通量血液透析优越性与待解决的问题[J]．临床肾脏杂志，2013，13(2): 54-55.
|
| [2] |
罗海燕，杨丽媛．不同血液净化方式对尿毒症患者生活质量影响的临床研究[J]．中国医疗前沿，2012，7(6)：27，63.
|
| [3] |
Eknoyan G, Beck GJ, Cheung AK, et al.Effect of dialysis dose and membrane flux in maintenance hemodialysis [J]. N Engl J Med, 2002, 347(25): 2010-2019.
|
| [4] |
史媛媛，吴淑华，陈雪，等．老年尿毒症患者高通量透析临床研究新进展．中国老年学杂志，2012，3: 1322-1324.
|
| [5] |
Malyszko JS, Malyszko J, Hryszko T, et al. Markers of endothelial damage in patients on hemodialysis and hemodiafiltration [J]．J Nephrol, 2006, 19(2): 150-154.
|
| [6] |
Raggi P, Vukicevic S, Moyses RM, et al. Ten-year experience with sevelamer and calcium salts as phosphate binders [J]. Clin J Am Soc Nephrol, 2010, 5(Suppl 1): S31-S40.
|
| [7] |
Penne EL, van der Weerd NC, Grooteman MP, et al. Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients [J]. Clin J Am Soc Nephrol, 2011, 6(2): 281-289.
|
| [8] |
Kong X, Zhang L, Zhang L, et al. Mineral and bone disorder in Chinese dialysis patients: a multicenter study [J]．BMC Nephrology, 2012, 13: 116.
|
| [9] |
Floege J, Kim J, Ireland E, et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population [J]. Nephrol Dial Transplant, 2011, 26(6): 1948-1955.
|
| [10] |
Shidara K, Inaba M, Okuno S, et al. Influence of nutritional status on serum large N-truncated PTH, but not PTH (1-84) in hemodialysis patients [J]. Biomed Pharmacother, 2007, 61(2/3): 142-147.
|
| [11] |
Lugon JR, Andre ME, Duarte ME, et al. Effects of incenter daily hemodialysis upon mineral metabolism and bone disease in end-stage renal disease patients [J]. Sao Paulo Med J, 2001, 119(3): 105-109.
|
| [12] |
龚德华，季大玺，陈惠萍，等．高通量维持性血液透析患者甲状旁腺激素水平及骨代谢的变化[J]．肾脏病与透析肾移植杂志，2001，10(4): 317-321.
|
| [13] |
Jordi B, Llach F. Renal osteodystrophies[M]//Brenner and Rector. The Kidney. Sixth edition. Singapore: Harcourt Asia WB Saunders, 2001: 2013-2186.
|
| [14] |
龚德华，季大玺，徐斌，等．高通量透析器的临床应用[J]．肾脏病与透析肾移植杂志，2002，11(5): 411-414.
|
| [15] |
许传文．高通量透析对血β2微球蛋白浓度及蛋白质浓度的影响[J]．临床内科学杂志，2005，22(6): 424-425.
|
| [16] |
Dember LM, Jaber BL. Dialysis-related amyloidosis: 1ate finding or hidden epidemic [J]. Semin Dial, 2006, 19(2): 105-109.
|
| [17] |
Leto E, Bilal F, Osmic I. Efficiency of high-flow dialyzers in removal of beta-2-mcroglobulin [J]. Med Arh, 2001, 55(4): 225-226.
|
| [18] |
刘艳，王荣，袁慧中．高通量透析对维持性血液透析患者血脂代谢的影响[J]．中国血液净化，2009，8(9)：492-494.
|
| [19] |
张学敏．高通量透析对尿毒症血液透析患者血脂代谢的影响[J]．实用心脑肺血管病杂志，2012，20(5)：802-803.
|
| [20] |
叶红波．高通量透析对维持性血透患者血脂代谢的影响[J]．吉林医药，2013，34(12)：2251-2252.
|
| [21] |
Otsubo Y, Uchida Y, Yasumoto Y，et al. Apo C III is a potent factor on lipid abnormalities in hemodialysis patients [J]. J Am Soc Nephrol, 1993, 4: 375(abstract)．
|
| [22] |
赵继红，田洁，李春红，等．高通量透析治疗对尿毒症血液透析患者血脂代谢的影响[J]．天津医药，2010，38(8)：680-682.
|
| [23] |
葛煜强，吴兆龙．应用促红细胞生成素改善血液透析患者的营养状况 [J]. 中华肾脏病杂志，1998，14(6): 373-375.
|
| [24] |
季大玺，谢红浪，陈惠萍，等．维持性血液透析患者肾性骨病的相关因素分析[J]．肾脏病与透析肾移植杂志，2000, 9(2): 113-116.
|
| [25] |
吴平勇，张庆红，张建鄂，等. 高通量透析可改善维持性血液透析患者肾性贫血[J]. 生物医学工程与临床，2005，9(1): 40-44.
|
| [26] |
Marcus RG, Cohl E, Uribarri J. Middle molecule clearance does not influence protein intake in hemodialysis patients [J]. Am J Kidney Dis, 1998, 31(3): 491-494.
|
| [27] |
Locatelli F, Martin-Malo A, Hannedouche T, et al. Effect of membrane permeability on survival of hemodialysis patients [J]. J Am Soc Nephrol, 2009, 20(3): 645-654.
|
| [28] |
Cheung AK, Levin NW, Greene T, et al. Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol, 2003, 14(12): 3251-3263.
|
| [29] |
Kim HW, Kim SH, Kim YO, et al. The impact of high-flux dialysis on mortality rates in incident and prevalent hemodialysis patients [J]. Korean J Intern Med, 2014, 29(6): 774-784.
|
| [30] |
刘丽平，卢方平．HEMO与MPO研究结果给我们的启示[J]．临床内科杂志，2011，28(5)：293-295.
|
| [31] |
龚德华，季大玺，谢红浪. 高通量透析器复用效果的临床观察[J]. 中华肾脏病杂志，2001，17(1): 49-50.
|
| [32] |
张启蒙，李杰，阿斯亚，等. 应用高通量可复用透析器透析对尿毒症患者血清蛋白丢失的观察[J]．中国血液净化，2009，8(10)：547-549.
|